Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Shares Outstanding (Diluted Average) (2018 - 2025)

Historic Shares Outstanding (Diluted Average) for Fortress Biotech (FBIO) over the last 8 years, with Q2 2025 value amounting to $29.8 million.

  • Fortress Biotech's Shares Outstanding (Diluted Average) rose 6282.35% to $29.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $29.8 million, marking a year-over-year increase of 6282.35%. This contributed to the annual value of $20.8 million for FY2024, which is 15625.17% up from last year.
  • As of Q2 2025, Fortress Biotech's Shares Outstanding (Diluted Average) stood at $29.8 million, which was up 6282.35% from $26.5 million recorded in Q1 2025.
  • Fortress Biotech's Shares Outstanding (Diluted Average)'s 5-year high stood at $101.9 million during Q1 2023, with a 5-year trough of $5.9 million in Q4 2022.
  • For the 5-year period, Fortress Biotech's Shares Outstanding (Diluted Average) averaged around $42.7 million, with its median value being $23.6 million (2024).
  • In the last 5 years, Fortress Biotech's Shares Outstanding (Diluted Average) plummeted by 9274.79% in 2022 and then skyrocketed by 16267.77% in 2024.
  • Over the past 5 years, Fortress Biotech's Shares Outstanding (Diluted Average) (Quarter) stood at $81.7 million in 2021, then plummeted by 92.75% to $5.9 million in 2022, then surged by 36.89% to $8.1 million in 2023, then skyrocketed by 156.25% to $20.8 million in 2024, then skyrocketed by 43.49% to $29.8 million in 2025.
  • Its last three reported values are $29.8 million in Q2 2025, $26.5 million for Q1 2025, and $20.8 million during Q4 2024.